46 studies found for:    stroke AND san diego | Open Studies
Show Display Options
Rank Status Study
21 Recruiting Cardiovascular Safety of Febuxostat and Allopurinol in Patients With Gout and Cardiovascular Comorbidities
Condition: Cardiovascular Disease
Interventions: Drug: Febuxostat;   Drug: Allopurinol
22 Recruiting A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients
Conditions: Heart Failure;   Respiratory Insufficiency;   Stroke Acute;   Infectious Diseases;   Rheumatic Diseases
Interventions: Drug: Rivaroxaban, 10 mg;   Drug: Rivaroxaban, 7.5 mg;   Drug: Placebo
23 Unknown  Oxygenation of the Cerebrum and Cooling During Transcatheter Aortic Valve Implantation (TAVI) Procedures - Part II
Conditions: Aortic Valve Stenosis;   Stroke
Interventions: Device: targeted brain cooling (33°C) by RhinoChill device;   Device: Placebo - current clinical practice, no cooling
24 Recruiting Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Placebo;   Drug: Linagliptin
25 Recruiting Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation FIBRILLATION
Conditions: Ventricular Tachycardia;   Atrial Fibrillation
Interventions: Drug: Ethanol;   Procedure: Ablation
26 Recruiting Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia
Condition: Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)
Interventions: Drug: Epanova® (omega-3 carboxylic acids);   Drug: corn oil control
27 Recruiting Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH-II)
Condition: Intracerebral Hemorrhage
Intervention: Drug: Nicardipine hydrochloride
28 Recruiting Efficacy and Safety Study of MYOBLOC® Followed by Open-Label Multiple-Treatment With MYOBLOC® in the Treatment of Troublesome Sialorrhea in Adult Subjects
Condition: Sialorrhea
Intervention: Drug: MYOBLOC
29 Recruiting A Long-Term Safety Trial of Treatment With Nebulized SUN-101 in Patients With COPD
Condition: Chronic Obstructive Pulmonary Disease (COPD)
Interventions: Drug: Glycopyrrolate (SUN-101 );   Drug: tiotropium (Spiriva®)
30 Recruiting Study Of Diabetic Nephropathy With Atrasentan
Condition: Diabetic Nephropathy
Interventions: Drug: Atrasentan;   Drug: Placebo
31 Recruiting A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High Risk Patients With Hypertriglyceridemia and on Statin. The Primary Objective is to Evaluate the Effect of 4 g/Day AMR101 for Preventing the Occurrence of a First Major Cardiovascular Event.
Condition: Cardiovascular Diseases
Interventions: Drug: AMR101;   Drug: Placebo
32 Recruiting A Study to Evaluate Cardiovascular Outcomes in Patients With Type 2 Diabetes Treated With ITCA 650
Condition: Type 2 Diabetes
Interventions: Drug: ITCA 650;   Other: ITCA placebo
33 Recruiting A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease
Condition: Crohn's Disease
Intervention: Drug: CP-690,550
34 Recruiting Safety and Efficacy of Low-Dose Ticagrelor in Chinese Patients With NSTE-ACS
Condition: Non ST Segment Elevation Acute Coronary Syndrome
Interventions: Drug: low-dose ticagrelor;   Drug: conventional-dose ticagrelor;   Drug: Clopidogrel
35 Recruiting Safety and Efficacy of Subjects With Critical Limb Ischemia
Condition: Critical Limb Ischemia
Intervention: Genetic: HGF Plasmid (AMG0001)
36 Recruiting Amiodarone, Lidocaine or Neither for Out-Of-Hospital Cardiac Arrest Due to Ventricular Fibrillation or Tachycardia
Condition: Cardiac Arrest
Interventions: Drug: amiodarone;   Drug: Lidocaine;   Other: Normal saline
37 Recruiting Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
Condition: Heart Failure With Preserved Ejection Fraction
Interventions: Drug: LCZ696;   Drug: Valsartan
38 Recruiting Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)
Conditions: FTLD;   Progressive Supranuclear Palsy (PSP);   Frontotemporal Dementia (FTD);   Corticobasal Degeneration (CBD);   PPA Syndrome;   Behavioral Variant Frontotemporal Dementia (bvFTD);   Semantic Variant Primary Progressive Aphasia (svPPA);   Nonfluent Variant Primary Progressive Aphasia (nfvPPA);   FTD With Amyotrophic Lateral Sclerosis (FTD/ALS);   Amyotrophic Lateral Sclerosis (ALS);   Oligosymptomatic PSP (oPSP);   Corticobasal Syndrome (CBS)
Intervention:
39 Recruiting Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III
Condition: Intracerebral Hemorrhage
Intervention: Drug: rt-PA
40 Recruiting Efficacy of Isradipine in Early Parkinson Disease
Condition: Parkinson Disease
Interventions: Drug: Isradipine;   Drug: Placebo (for Isradipine)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-46) Show next page of results    Last Page
Indicates status has not been verified in more than two years